MedPath

Management of split-thickness skin graft donor site: An open, prospective, randomized, controlled clinical trial for comparison of three different dressing materials.

Phase 4
Conditions
Split-skin grafting donor sites
Registration Number
DRKS00030018
Lead Sponsor
QRSKIN GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
69
Inclusion Criteria

patients scheduled for elective skin grafting were eligible for inclusion in the study

Exclusion Criteria

age under 18 years, pregnancy / lactation, local infection at planned split-thickness skin grafting donor site, hypersensitivity to dressing components, malignant or autoimmune disease, vasculitis, connective tissue diseases, immune system disorders, chemo-, radio- and immunosuppressive therapy within 30 days prior to study enrolment, systemic corticosteroids (intake > 10mg/day), drug abuse, excessive alcohol consumption, recent participation in other clinical trials within 4 weeks before study enrolment.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)time-to-healing (days until complete re-epithelialisation daily until the 14th postoperative day)<br>2Hollander Wound Evaluation Scale<br>(wound assessment following dressing removal using the validated Hollander Wound Evaluation ScaleEvaluation Scale<br>daily until the 14th postoperative day)<br>3intensity of pain<br>(intensity of pain before, during and after dressing change and at rest/motion using visual analogue scale (0 indicating no pain; 10 indicating unbearable pain)<br>daily until the 14th postoperative day)<br>4extent of subjective dressing handling<br>(extent of subjective dressing handling (ease of use) after dressing changes using a 4-item<br>daily until the 14th postoperative day)<br>
Secondary Outcome Measures
NameTimeMethod
scar quality at 3, 6 and 12 months following split-thickness skin grafting donor site collection.<br>
© Copyright 2025. All Rights Reserved by MedPath